Article
2003 ANTIVIRAL ACTIVITY, PHARMACOKINETICS, AND TOLERABILITY OF AZD7295, A NOVEL NS5A INHIBITOR, IN A PLACEBO-CONTROLLED MULTIPLE ASCENDING DOSE STUDY IN HCV GENOTYPE 1 AND 3 PATIENTS
2010-04-01
Abstract excerpt
No abstract is available from the source.
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cd9dbda9-b1d8-535c-86ee-5b6202da61bc
- DOI
- 10.1016/s0168-8278(10)61194-4
